Literature DB >> 16710978

Human pythiosis.

Jakrapun Pupaibool, Ariya Chindamporn, Kanitha Patrakul, Chusana Suankratay, Wannasri Sindhuphak, Wanla Kulwichit.   

Abstract

Entities:  

Mesh:

Year:  2006        PMID: 16710978      PMCID: PMC3291453          DOI: 10.3201/eid1203.051044

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Over the past 2 decades, human pythiosis has emerged as an important parafungal disease; Thailand reports the most cases (,). Given the rarity of this infection in humans and the limited attention of researchers to the disease, our understanding of its pathogenesis and other important traits, including its management, await investigation. We report 2 distinct cases. The first patient was a 63-year-old woman with hemoglobin AEBart's disease, a complex thalassemia/hemoglobinopathy syndrome, which required frequent blood transfusions. Two months before admission, after a major flood and exposure to standing water for weeks, an abnormal sensation developed in her right foot, which progressed to pain and intermittent claudication. Subsequent inability to walk prompted her to seek medical assistance. At admission, she was febrile with absence of pulses on the right lower extremity and a diminished pulse on the left. She had a peripheral blood eosinophilia of 10%. Emergency femoral angiography indicated complete obstruction of the right common iliac and left internal iliac arteries (Figure) with collateral supplies via lumbar arteries. Surgical intervention demonstrated a white clot from aortic bifurcation down to the right common iliac artery and the superficial and deep femoral arteries, surrounded by necrotic tissue and enlarged inguinal nodes. Right femoral embolectomy and aortofemoral bypass were performed. A 10% KOH preparation of the clot and dissected nodes showed branching septate hyphae. Cultures of these specimens grew Pythium insidiosum. Itraconazole solution, terbinafine, and therapeutic vaccines () were administered. Extended-spectrum antimicrobial agents were also given during her hospital stay to combat nosocomial infections. Progressive wound necrosis and gangrene of the limbs dictated multiple debridements and subsequent limb amputations and hip disarticulation. Her clinical course worsened, and she died 2 months after admission. The second patient was a 15-year-old boy with β-thalassemia/hemoglobin E disease, 10 years after splenectomy. The patient received frequent blood transfusions and monthly intravenous deferoxamine for secondary hemochromatosis. Six days before admission to our hospital, necrotizing cellulitis of both legs, unresponsive to intravenous antimicrobial agents, was diagnosed at a local hospital. The patient reported frequent swimming in standing water in rice fields. He was febrile with a leukocyte count of 26,000/mm3 and was given broad-spectrum intravenous antimicrobial agents. Severity of the lesions demanded surgical debridement (Figure A1), which showed necrosis of skin and subcutaneous tissue but intact fasciae and muscles. Tissue pathology and fungal staining did not demonstrate the etiologic agent. Surgical tissue Gram's stain and culture were nonrevealing, but fungal culture grew P. insidiosum after a few days. Isolates demonstrated white submerged colonies and microscopically showed sparsely septate hyphae 4–10 μm in diameter. Boiled grass blades were transferred onto the agar with the growth and incubated at 37°C for 24 hours. The blades were then put in a container with dilute salt solution for 2 hours at 35°C. They were subsequently placed on a slide, and mobile biflagellate zoospores were seen. Serum antibodies to P. insidiosum by immunodiffusion were detected in both cases. Femoral angiography showed no abnormalities. Since therapeutic immunogens were not available during that period, a combination of supersaturated potassium iodide (SSKI), itraconazole, and terbinafine was initiated. SSKI was discontinued after a month because of side effects. Lesions were progressive involving fasciae and muscles and necessitated 2 episodes of surgical debridement during the first month. The lesions began to improve in the second month of medical therapy, when skin grafting was performed. The patient remained well and was discharged after almost 3 months. Medications were continued for a total period of 6 months. The patient has been well for >2 years.
Figure A1

Surgically debrided lesions.

P. insidiosum in tissues resembles agents of zygomycosis morphologically but, unlike the latter, rarely stains with hematoxylin and eosin. Various immunostainings also help identify the organism (). With the exception of the facial-cranial form of the disease in the United States (), most cases in Thailand occur in patients with chronic hemolytic anemia; thalassemia-hemoglobinopathy is the most common underlying disease. Major clinical manifestations include ocular and craniofacial infections in healthy children, arteritis usually originating from lower extremities, and chronic subcutaneous abscesses. Treatment options reported to be successful include supersaturated potassium iodide for the chronic cutaneous form (), a combination of terbinafine and itraconazole in a single case of an acute, severe ocular, subcutaneous infection (), and therapeutic vaccination for severe infections involving major arteries (,) in conjunction with surgery. The first case suggested that, with chronic pythiosis involving the aorta, effective management is difficult. In the second case, the laboratory was familiar with P. insidiosum isolation procedures; therefore, a quick diagnosis was made and early treatment was instituted. This early form of cutaneous pythiosis is rarely diagnosed properly by most clinical and pathologic laboratories. Human cases probably occur worldwide () but are underrecognized and thus, misdiagnosed (). More research into the pathogenesis, diagnosis, and new treatment modalities is urgently needed. Femoral angiography of patient 1 demonstrating involvement of the right common iliac artery upward to the aorta and extending to the left internal iliac artery.
  9 in total

Review 1.  Penicilliosis marneffei and pythiosis: emerging tropical diseases.

Authors:  L Kaufman
Journal:  Mycopathologia       Date:  1998       Impact factor: 2.574

2.  Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child.

Authors:  J L Shenep; B K English; L Kaufman; T A Pearson; J W Thompson; R A Kaufman; G Frisch; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

3.  Use of an immunotherapeutic vaccine to treat a life-threatening human arteritic infection caused by Pythium insidiosum.

Authors:  A Thitithanyanont; L Mendoza; A Chuansumrit; R Pracharktam; J Laothamatas; B Sathapatayavongs; S Lolekha; L Ajello
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

Review 4.  Human pythiosis.

Authors:  M Thianprasit; A Chaiprasert; P Imwidthaya
Journal:  Curr Top Med Mycol       Date:  1996-12

5.  Efficacy of immunotherapy using antigens of Pythium insidiosum in the treatment of vascular pythiosis in humans.

Authors:  Wanchai Wanachiwanawin; Leonel Mendoza; Sanan Visuthisakchai; Piroon Mutsikapan; Boonmee Sathapatayavongs; Angkana Chaiprasert; Parvinee Suwanagool; Worapong Manuskiatti; Chanian Ruangsetakit; Libero Ajello
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

Review 6.  Orbital pythiosis: a non-fungal disease mimicking orbital mycotic infections, with a retrospective review of the literature.

Authors:  L Mendoza; S H Prasla; L Ajello
Journal:  Mycoses       Date:  2004-02       Impact factor: 4.377

Review 7.  Human pythiosis associated with thalassemia hemoglobinopathy syndrome.

Authors:  B Sathapatayavongs; P Leelachaikul; R Prachaktam; V Atichartakarn; S Sriphojanart; P Trairatvorakul; S Jirasiritham; S Nontasut; C Eurvilaichit; T Flegel
Journal:  J Infect Dis       Date:  1989-02       Impact factor: 5.226

8.  An improved Pythium insidiosum-vaccine formulation with enhanced immunotherapeutic properties in horses and dogs with pythiosis.

Authors:  Leonel Mendoza; William Mandy; Robert Glass
Journal:  Vaccine       Date:  2003-06-20       Impact factor: 3.641

9.  Human pythiosis, Brazil.

Authors:  Sandra de Moraes Gimenes Bosco; Eduardo Bagagli; João Pessoa Araújo; João Manuel Grisi Candeias; Marcello Fabiano de Franco; Mariangela Esther Alencar Marques; Leonel Mendoza; Rosangela Pires de Camargo; Silvio Alencar Marques
Journal:  Emerg Infect Dis       Date:  2005-05       Impact factor: 6.883

  9 in total
  5 in total

1.  In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.

Authors:  Juliana S Argenta; Janio M Santurio; Sydney H Alves; Daniela I B Pereira; Ayrton S Cavalheiro; Andréia Spanamberg; Laerte Ferreiro
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

2.  Vascular pythiosis in a thalassemic patient presenting as bilateral leg ulcers.

Authors:  Nicha Keoprasom; Leena Chularojanamontri; Methee Chayakulkeeree; Angkana Chaiprasert; Wanchai Wanachiwanawin; Chanean Ruangsetakit
Journal:  Med Mycol Case Rep       Date:  2012-12-08

3.  Hemagglutination test for rapid serodiagnosis of human pythiosis.

Authors:  Thanyasiri Jindayok; Savittree Piromsontikorn; Somboon Srimuang; Kalayanee Khupulsup; Theerapong Krajaejun
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

4.  Development of an immunochromatographic test for rapid serodiagnosis of human pythiosis.

Authors:  Theerapong Krajaejun; Srisurat Imkhieo; Akarin Intaramat; Kavi Ratanabanangkoon
Journal:  Clin Vaccine Immunol       Date:  2009-02-18

5.  Photodynamic therapy in Pythium insidiosum - an in vitro study of the correlation of sensitizer localization and cell death.

Authors:  Layla Pires; Sandra de Moraes Gimenes Bosco; Maurício S Baptista; Cristina Kurachi
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.